Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Trials

MRD trials

The curated index is a sourced list of studies. Accruing is the live ClinicalTrials.gov set of studies that are recruiting or not yet recruiting. DYNAMIC-III is not in the curated index because it is registered in Australia and New Zealand, not with an NCT id.

Recruiting and not-yet-recruiting studies that use ctDNA, cfDNA, or MRD in eligibility, a treatment decision, or a primary or secondary endpoint, plus observational studies focused on that testing. 1123 studies from 2267 registry records. Hematologic trials that list MRD only as a secondary endpoint are listed separately. Last synced Nov 18, 2026, 2:04 PM EST.

  • GI · GastroesophagealNot yet recruitingPhase 3NCT06914011

    Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma

    Asan Medical Center · Locations not reported · Updated 2026-10-29

  • GI · GastroesophagealNot yet recruitingPhase 2 / Phase 3NCT07653451

    Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer

    Peking University Cancer Hospital & Institute · Locations not reported · Updated 2026-06-17

  • GI · GastroesophagealNot yet recruitingPhase 3NCT07508956

    Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment

    Shanghai Zhongshan Hospital · 1 locations · Updated 2026-06-08

  • GI · GastroesophagealNot yet recruitingPhase 3NCT05244798

    Sintilimab Plus NCT or NCRT Versus NCRT for ESCC

    Sichuan Cancer Hospital and Research Institute · 1 locations · Updated 2022-10-25

  • GI · GastroesophagealNot yet recruitingPhase 2NCT07788664

    Local and Systemic Immune Modulation by Rilvegostomig (AZD2936) in the Treatment of Advanced Gastric Cancer (RILVE Project)

    Vall d'Hebron Institute of Oncology · 3 locations · Updated 2026-11-12

  • GI · GastroesophagealRecruitingPhase 2NCT07018570

    An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

    National Cancer Center Hospital East · 1 locations · Updated 2026-11-02

  • GI · GastroesophagealRecruitingPhase 2NCT06601309

    Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC

    Fujian Medical University Union Hospital · 1 locations · Updated 2026-10-29

  • GI · GastroesophagealRecruitingPhase 2NCT05563766

    A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

    VA Office of Research and Development · 7 locations · Updated 2026-10-09

  • GI · GastroesophagealRecruitingPhase 2NCT07290985

    AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas

    American Association for Cancer Research · 4 locations · Updated 2026-10-05

  • GI · GastroesophagealRecruitingPhase 2NCT06253650

    Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease

    Gruppo Oncologico del Nord-Ovest · 1 locations · Updated 2026-09-23

  • GI · GastroesophagealRecruitingPhase 2NCT07222657

    Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma

    Case Comprehensive Cancer Center · 1 locations · Updated 2026-08-18

  • GI · GastroesophagealRecruitingPhase 2NCT06829797

    A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined With SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

    Shandong Provincial Hospital · 1 locations · Updated 2026-04-29

  • GI · GastroesophagealRecruitingPhase 2NCT07537348

    Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and Immunotherapy in Advanced Gastric Cancer

    Qilu Hospital of Shandong University · 1 locations · Updated 2026-04-17

  • GI · GastroesophagealRecruitingPhase 2NCT07537361

    Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer

    Qilu Hospital of Shandong University · 1 locations · Updated 2026-04-17

  • GI · GastroesophagealRecruitingPhase 2NCT07517107

    Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer

    Fudan University · 1 locations · Updated 2026-04-08

  • GI · GastroesophagealNot yet recruitingPhase 2NCT07507916

    Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma

    Fudan University · Locations not reported · Updated 2026-04-02

  • GI · GastroesophagealRecruitingPhase 2NCT06161818

    Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction

    Erasmus Medical Center · 10 locations · Updated 2025-12-22

  • GI · Pancreatic, Gastroesophageal, ColorectalRecruitingPhase 2NCT06333314

    Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

    UNICANCER · 22 locations · Updated 2025-12-02

  • GI · GastroesophagealNot yet recruitingPhase 2NCT07257380

    Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)

    Shanghai Zhongshan Hospital · 1 locations · Updated 2025-12-02

  • GI · GastroesophagealRecruitingPhase 2NCT07152678

    Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma

    National Taiwan University Hospital · 1 locations · Updated 2025-09-03

  • GI · GastroesophagealNot yet recruitingPhase 2NCT06933966

    Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

    Centre Leon Berard · 3 locations · Updated 2025-04-18

  • GI · GastroesophagealRecruitingPhase 2NCT06430658

    Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 1 locations · Updated 2024-12-27

  • GI · GastroesophagealRecruitingPhase 2NCT05965479

    Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer

    University of Southampton · 14 locations · Updated 2024-11-12

  • GI · GastroesophagealNot yet recruitingPhase 2NCT06469060

    Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction

    Shanghai Chest Hospital · 1 locations · Updated 2024-07-01

  • GI · GastroesophagealNot yet recruitingPhase 2NCT06178211

    Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial

    Shanghai Chest Hospital · 1 locations · Updated 2023-12-20

  • GI · GastroesophagealRecruitingPhase 2NCT05494060

    XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma

    The First Affiliated Hospital with Nanjing Medical University · 1 locations · Updated 2023-11-07

  • GI · GastroesophagealRecruitingNot applicableNCT07884669

    Biomarker Investigation for Early Gastric Cancer Detection

    Centre Leon Berard · 1 locations · Updated 2026-11-17

  • GI · GastroesophagealNot yet recruitingNot reportedObservationalNCT07939997

    ctDNA Observational Biomarker Validation Study for Evaluation of Esophageal Squamous Cell Carcinoma

    University of Colorado, Denver · 1 locations · Updated 2026-11-16

  • GI · Gastroesophageal, ColorectalRecruitingNot reportedObservationalNCT07829081

    Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

    University Hospital, Basel, Switzerland · 3 locations · Updated 2026-09-18

  • GI · GastroesophagealRecruitingNot reportedObservationalNCT06308510

    Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer

    Erasmus Medical Center · 1 locations · Updated 2026-09-14

  • GI · GastroesophagealNot yet recruitingNot reportedObservationalNCT07799649

    ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR

    The First Affiliated Hospital with Nanjing Medical University · 1 locations · Updated 2026-09-02

  • GI · Pancreatic, GastroesophagealRecruitingNot applicableNCT07660627

    Determining Minimal Residual Disease Using ctDNA Deep Sequencing

    Masaryk Memorial Cancer Institute · 1 locations · Updated 2026-06-24

  • GI · GastroesophagealRecruitingNot applicableNCT04560036

    FAZA PETMRI Gastro-Oesophageal Study

    University Health Network, Toronto · 1 locations · Updated 2026-06-10

  • GI · GastroesophagealRecruitingNot applicableNCT05704530

    Liquid Biopsies in Esophageal Cancer

    Universitaire Ziekenhuizen KU Leuven · 4 locations · Updated 2026-06-01

  • GI · Pancreatic, Gastroesophageal, ColorectalNot yet recruitingNot reportedObservationalNCT07574957

    Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNA

    Assistance Publique - Hôpitaux de Paris · Locations not reported · Updated 2026-05-08

  • GI · GastroesophagealNot yet recruitingNot applicableNCT07565857

    Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer

    Natera, Inc. · Locations not reported · Updated 2026-05-04

  • GI · GastroesophagealRecruitingNot reportedObservationalNCT06893133

    ctDNA-MRD Monitoring After Resection in Gastric Cancer

    Peking University · 1 locations · Updated 2026-04-21

  • GI · GastroesophagealRecruitingPhase 1NCT05733689

    Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

    University of California, Irvine · 1 locations · Updated 2026-03-10

  • GI · GastroesophagealRecruitingPhase 1NCT07317609

    Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)

    Shanghai Zhongshan Hospital · 1 locations · Updated 2026-01-05

  • GI · GastroesophagealNot yet recruitingNot reportedObservationalNCT07152535

    Multi-omics Monitoring of Dynamic Evolution in Esophageal Squamous Cell Carcinoma: PKU-ESCC-Monitor

    Peking University Cancer Hospital & Institute · Locations not reported · Updated 2025-09-03

Showing 1–40 of 47. Older studies

Status can change after this sync. The curated list is the other view on this page. Evidence holds the published results.